{"doc_desc":{"title":"Descriptive pharmaco-epidemiological study on the use of Symbicort\u00ae Turbuhaler\u00ae in the treatment of asthma in France and impact of a new treatment strategy on compliance and asthma control","idno":"FRESH-PEF188-en","producers":[{"name":"Pascal PIEDBOIS","affiliation":"GCS INSTITUT DE CANCEROLOGIE STRASBOURG EUROPE (GCS ICANS)"}]},"study_desc":{"title_statement":{"idno":"FRESH-PEF188-en","IDno":{"metadata_no":[{"agency":"PEF","code":"188"},{"agency":"FReSH","code":"FRESH-PEF188"}]},"title":"Descriptive pharmaco-epidemiological study on the use of Symbicort\u00ae Turbuhaler\u00ae in the treatment of asthma in France and impact of a new treatment strategy on compliance and asthma control","alternate_title":"SYMBIOSE"},"study_authorization":{"agency":[]},"authoring_entity":[{"type":"investigator","name":"Florence;THOMAS-DELECOURT","PILabo":"AstraZeneca","affiliationName":"ASTRAZENECA (FRANCE)","extlink":[{"title":"","uri":"","role":"pi id"},{"title":"","uri":"","role":"pi id"},{"title":"SIREN","uri":"558201075","role":"organisation id"},{"title":"","uri":"","role":"labo id"}],"email":"florence.thomas@astrazeneca.com","isContact":"Yes"},{"type":"investigator","name":"Pascal;PIEDBOIS","PILabo":"Centre Paul Strauss","affiliationName":"GCS INSTITUT DE CANCEROLOGIE STRASBOURG EUROPE (GCS ICANS)","extlink":[{"title":"","uri":"","role":"pi id"},{"title":"","uri":"","role":"pi id"},{"title":"SIREN","uri":"794139246","role":"organisation id"},{"title":"","uri":"","role":"labo id"}],"email":"pascal.piedbois@one2treat.com","isContact":"Yes"}],"oth_id":[{"name":""}],"production_statement":{"prod_place":"Epidemiology France Portal (PEF)","producers":[{"name":"ASTRAZENECA (FRANCE)","extlink":[{"title":"ROR","uri":"https:\/\/ror.org\/016qv5070","role":"sponsor id"},{"title":"SIREN","uri":"558201075","role":"sponsor id"}],"role":"sponsor"}],"funding_agencies":[{"name":"ASTRAZENECA (FRANCE)","extlink":[{"title":"ROR","uri":"https:\/\/ror.org\/016qv5070"},{"title":"SIREN","uri":"558201075"}]}]},"distribution_statement":{"contact":[{"name":"Florence;THOMAS-DELECOURT","email":"florence.thomas@astrazeneca.com","type":"contact","affiliationName":"ASTRAZENECA (FRANCE)","contactPointLabo":"","extlink":[{"uri":"https:\/\/ror.org\/016qv5070","role":"organisation id","title":"ROR"},{"uri":"558201075","role":"organisation id","title":"SIREN"}]},{"name":"Pascal;PIEDBOIS","email":"pascal.piedbois@one2treat.com","type":"contact","affiliationName":"GCS INSTITUT DE CANCEROLOGIE STRASBOURG EUROPE (GCS ICANS)","contactPointLabo":"","extlink":[{"uri":"https:\/\/ror.org\/008fdbn61","role":"organisation id","title":"ROR"},{"uri":"794139246","role":"organisation id","title":"SIREN"}]}]},"study_info":{"keywords":[{"keyword":"Symbicort\u00ae Turbuhaler\u00ae"},{"keyword":"cohort"}],"topics":[{"topic":"Pulmonary medicine","vocab":"health theme","extLink":[{"title":"ESV","uri":"http:\/\/data.europa.eu\/8mn\/euroscivoc\/f6e18c52-6087-4662-904c-5c4b8174e40e"},{"title":"MeSH","uri":"http:\/\/id.nlm.nih.gov\/mesh\/D015272"}]},{"topic":"Healthcare system determinants: Use of care","vocab":"health determinant"},{"topic":"Healthcare system determinants","vocab":"health determinant"}],"purpose":"Describe the characteristics of asthmatic patients treated with Symbicort Turbuhaler Compare the characteristics of patients treated according to the therapeutic strategy Evaluate the level of asthma control and compliance with treatment of patients treated with Symbicort Turbuhaler","abstract":"","coll_dates":[{"start":"2009-01-01","end":"2011-01-01"}],"nation":[{"name":"France","abbreviation":"fr","extLink":{"vocab":"ISO","vocabURI":"fr"}}],"geog_coverage":"","analysis_unit":"Individuals","universe":"{\n    \"level_sex_clusion_I\": [\n        {\n            \"value\": \"Male\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D008297\"\n            }\n        },\n        {\n            \"value\": \"Female\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D005260\"\n            }\n        }\n    ],\n    \"level_age_clusion_I\": [\n        {\n            \"value\": \"Child (6 to 12 years)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D002648\"\n            }\n        },\n        {\n            \"value\": \"Young Adult (19 to 24 years)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D055815\"\n            }\n        },\n        {\n            \"value\": \"Adult (25 to 44 years)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D000328\"\n            }\n        },\n        {\n            \"value\": \"Middle Aged (45 to 64 years)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D008875\"\n            }\n        },\n        {\n            \"value\": \"Aged (65 to 79 years)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D000368\"\n            }\n        },\n        {\n            \"value\": \"Aged, 80 and over (80 years and more)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D000369\"\n            }\n        }\n    ],\n    \"level_type_clusion_I\": \"Patients population\",\n    \"level_type_clusion_other\": \"\",\n    \"clusion_I\": \"Patients diagnosed as asthmatic by the physician and treated for this pathology with Symbicort Turbuhaler\",\n    \"clusion_E\": \"\"\n}","data_kind":"['Clinical data','Participant-reported health data']","quality_statement":{"standards":[{"name":"","committee":"","governance":""}],"other_quality_statement":""}},"study_development":{"development_activity":[{"activity_type":"primary evaluation","activity_description":"Health event\/morbidity\r\nQuality of life\/health perception"}]},"method":{"data_collection":{"time_method":"","frequency":"","sampling_procedure":"['{\"concept\":{\"vocabURI\":\"Other\",\"vocab\":\"CESSDA\"},\"value\":\"Other\"}']","sample_frame":{"frame_unit":{"unit_type":"['Through organizations (health services or institutions, schools, businesses, etc.)']"}},"coll_mode":["{\"concept\":{\"vocabURI\":\"Transcription\",\"vocab\":\"CESSDA\"},\"value\":\"Converting or copying information into a structured record\"}","{\"concept\":{\"vocabURI\":\"Interview\",\"vocab\":\"CESSDA\"},\"value\":\"Interview with the participant (including clinical)\"}"],"research_instrument":"Access on specific project only","sources":[],"target_sample_size":"[1000-10000[ individuals","response_rate":"1844"},"method_notes":"Observational Study","study_class":"Unknown","notes":[{"subject":"research type","values":["Observational Study"]}]},"data_access":{"dataset_availability":{"access_place":"","complete":"","status":"{\"value\":\"To be defined\",\"extLink\":[]}"},"dataset_use":{"restrictions":"","conditions":"","conf_dec":[{"txt":""}],"spec_perm":[{"txt":"","required":""}],"contact":[{"name":""}],"deposit_req":"","cit_req":""},"notes":""}},"additional":{"IsImport":true,"versionLang":"en","originLang":"en","autoTranslation":false,"status":"imported","creationDate":"12-04-2011","lastUpdatedAuto":null,"lastUpdatedManual":"13-12-2013","isContributorPI":"No","contributorName":"Pascal PIEDBOIS","contributorAffiliation":"GCS INSTITUT DE CANCEROLOGIE STRASBOURG EUROPE (GCS ICANS)","addTeamMember":"","obtainedAuthorization":{"otherAuthorizingAgency":[]},"relatedDocument":[],"regulatoryRequirements":{"conformityDeclaration":""},"fundingAgent":{"fundingAgentType":["Industry"],"otherFundingAgentType":[""]},"sponsor":{"sponsorType":["Industry"],"otherSponsorType":[""]},"governance":{"committee":""},"collaborations":{"networkConsortium":""},"theme":{"complementaryInformation":"","RareDiseases":""},"activeFollowUp":{"isActiveFollowUp":"Yes","followUpModeOther":""},"interventionalStudy":{"researchPurpose":[],"trialPhase":[],"interventionalStudyModel":"","isClinicalTrial":"","otherResearchPurpose":""},"isInclusionGroups":"","allocation":{"allocationMode":"","allocationUnit":""},"masking":{"maskingType":"","blindedMaskingDetails":[]},"arms":[],"intervention":[],"inclusionGroups":[],"collectionProcess":{"collectionModeDetails":"","collectionModeOther":""},"dataCollection":{"inclusionStrategyOther":"","samplingModeOther":"","recruitmentSourceOther":"","otherDocumentation":""},"dataCollectionIntegration":{"isDataIntegration":"No"},"geographicalCoverage":{"geoDetail":"France"},"dataTypes":{"clinicalDataDetails":"","biologicalDataDetails":"","isDataInBiobank":"No","biobankContent":[],"biobankContentOther":"","dataTypeOther":""},"variableDictionnary":{"variableDictionnaryAvailable":"","variableDictionnaryLink":""},"dataQuality":{"otherDocumentation":""},"mockSample":{"mockSampleAvailable":"","mockSampleLocation":""},"thirdPartySource":{"otherSourceType":[]},"isHealthTheme":"Yes","fileDscr":{"fileTxt":{"fileCitation":{"titlStmt":{"IDno":[]}}}}},"schematype":"survey"}